Study: Hormone therapy may impact results of mammograms, biopsies

02/25/2008 | Forbes

A U.S. study found that patients who received combined hormone replacement therapy for about five years are more likely to have abnormal mammograms and breast biopsies compared with those who received a placebo. The findings suggest that HRT may affect the efficacy of the tests in breast cancer diagnosis. A doctor said women need to be more aware of the risks involved in HRT.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA